BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2383 related articles for article (PubMed ID: 15882617)

  • 1. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Orimo A; Gupta PB; Sgroi DC; Arenzana-Seisdedos F; Delaunay T; Naeem R; Carey VJ; Richardson AL; Weinberg RA
    Cell; 2005 May; 121(3):335-48. PubMed ID: 15882617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal fibroblasts in cancer: a novel tumor-promoting cell type.
    Orimo A; Weinberg RA
    Cell Cycle; 2006 Aug; 5(15):1597-601. PubMed ID: 16880743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
    Kojima Y; Acar A; Eaton EN; Mellody KT; Scheel C; Ben-Porath I; Onder TT; Wang ZC; Richardson AL; Weinberg RA; Orimo A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20009-14. PubMed ID: 21041659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
    Burger JA; Kipps TJ
    Blood; 2006 Mar; 107(5):1761-7. PubMed ID: 16269611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
    Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion.
    Benyahia Z; Dussault N; Cayol M; Sigaud R; Berenguer-Daizé C; Delfino C; Tounsi A; Garcia S; Martin PM; Mabrouk K; Ouafik L
    Oncotarget; 2017 Feb; 8(9):15744-15762. PubMed ID: 28178651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
    Al-Ansari MM; Hendrayani SF; Shehata AI; Aboussekhra A
    Oncogene; 2013 May; 32(18):2356-64. PubMed ID: 22751126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coevolution of cancer and stromal cellular responses.
    Littlepage LE; Egeblad M; Werb Z
    Cancer Cell; 2005 Jun; 7(6):499-500. PubMed ID: 15950897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
    Al-Rakan MA; Hendrayani SF; Aboussekhra A
    BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion.
    Fang D; Sun L; Lin S; Zhou L; Su N; Yuan S; Yu B
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1045-55. PubMed ID: 22946087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 18. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
    Libura J; Drukala J; Majka M; Tomescu O; Navenot JM; Kucia M; Marquez L; Peiper SC; Barr FG; Janowska-Wieczorek A; Ratajczak MZ
    Blood; 2002 Oct; 100(7):2597-606. PubMed ID: 12239174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.
    Kryczek I; Wei S; Keller E; Liu R; Zou W
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C987-95. PubMed ID: 16943240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 120.